This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M et al. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 967–972.
Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis if engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961–3969.
Foïs E, Desmartin M, Benhamida S, Xavier F, Vanneaux V, Rea D et al. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations. Bone Marrow Transplant 2007; 40: 831–835.
Rowley SD . Techniques of bone marrow and stem cells cryopreservation and storage. In: Sacher RA, Aubuchon JP (eds).. Marrow Transplantation: Practice and Technical Aspects of Stem Cells Reconstitution. American Association of Blood Banks: Bethesda, MD, USA, 1992 pp 105–127.
Jansen J, Thompson JM, Dugan MJ, Nolan P, Wiemann MC, Birhiray R et al. Peripheral blood progenitor cell transplantation. Ther Apher 2002; 6: 5–14.
Hicks C, Wong R, Manoharan A, Kwan YL . Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Ann Hematol 2007; 86: 591–598.
Lefrère F, Delarue R, Somme D, Levy V, Damaj G, Tu A et al. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose. Transfusion 2002; 42: 443–450.
Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162–2169.
Lioznov MV, Freiberger P, Kröger N, Zander AR, Fehse B . Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 35: 909–914.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bai, L., Xia, W., Wong, K. et al. Infused neutrophil dose and haematopoietic recovery in patients undergoing autologous transplantation. Bone Marrow Transplant 49, 725 (2014). https://doi.org/10.1038/bmt.2014.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.14